思连康联合思密达治疗小儿轮状病毒性肠炎临床观察

目的评价思连康联合思密达治疗小儿轮状病毒性肠炎的临床疗效。方法对120例小儿轮状病毒性肠炎患儿随机分为4组,A组为对照组,给予抗病毒、补液、纠酸等常规治疗,在此基础上,B组加用思连康,C组加用思密达,D组加用思连康联合思密达治疗,比较4组临床疗效。结果A、B、C和D组的总有效率分别为27.34%、56.67%、53.33%和83.34%,平均止泻时间分别为（133.20±41.89）h、（87.56±34.63）h、（88.07±36.24）h和（68.63±29.48）h。无论总有效率或平均止泻时间,治疗组与对照组相比,差异均有显著性（P〈0.05）,而又以D组疗效最好,与B组或C组相比,差异均有显著性（P均〈0.05）。结论思连康联合思密达治疗小儿轮状病毒性肠炎的疗效肯定,值得临床推广使用。

The comparison of the therapeutic effects smecta and siliankang in treatment of rotavirus enteritis in young children

Objective To evaluate the clinical effect of clinical smecta and siliankang for curing rotavirus enteritis in young children. Methods A total of 120 cases of rotavirus entertis in young children were divided randomly into four groups. Group A were given regular synthetical therapy. On a basis of regular therapy, Group B were additionally treated with siliankang, Group C with smecta and Group D with siliankang and smecta. Then the results of all groups were compared. Re- stilts The total effective rate of four groups were 27.34% ,56.67% ,53.33% ,83.34% , respectively. The time of recovery were （ 133.20 ± 41.89 ） h, （ 87.56 ± 34.63 ） h, （ 88.07 ± 36.24） h,68.63 ± 29.48 ） h, respectively. There was significant difference （ P 〈 0.05 ） between treated groups and control group. And the therapeatic effects of group D were the best, com- pared with group B and C （ P 〈 0.05 ）. Conclusion The combination regimen of siliankang and smecta can remarkably increase the cured rate and shorten the recovery time with an important clinical significance.